Characterization of vascular P2 purinoceptors in the rat isolated perfused kidney

European Journal of Pharmacology

Volumn 306, Issue 1-3, 1996, Pages 139-152

  Eltze, Manfrid ^a   Ullrich, Brigitte ^a  

^a Department of Pharmacology ^*  (Germany)

Author keywords

kidney, perfused, rat; purinoceptor agonist; purinoceptor antagonist; purinoceptor P(2U); purinoceptor P(2X); purinoceptor P(2Y)

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; 8 PHENYLTHEOPHYLLINE; ADENOSINE 5' O (3 THIOTRIPHOSPHATE); ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ARECAIDINE PROPARGYL ESTER; ARGININE; CIBACRON BLUE F3GA; EVANS BLUE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROBENZYLTHIOINOSINE; PURINE P2 RECEPTOR; PURINE P2 RECEPTOR AGONIST; PURINE P2 RECEPTOR ANTAGONIST; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; PURINE P2Y2 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SURAMIN; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE; ANTITRYPANOSOMAL AGENT; DRUG DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; ISOLATED KIDNEY; KIDNEY BLOOD FLOW; KIDNEY PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION; ANIMAL; DRUG EFFECT; KIDNEY; PERFUSION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; EVANS BLUE; KIDNEY; MALE; MUSCLE, SMOOTH, VASCULAR; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2; SURAMIN; TRYPANOCIDAL AGENTS; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATION;

EID: 0030582059     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00244-0     Document Type: Article

References (53)

1. Abbracchio, M.P., F. Cattabeni, B.B. Fredholm and M. Williams, 1993, Purinoceptor nomenclature, A status report, Drug. Dev. Res. 28, 207.
2. Beukers, M.W., C.J.M. Kerkhof, M.A. van Rhee, U. Ardanuy, C. Gurgel, H. Widjaja, P. Nickel, A.P. Uzerman and W. Soudijn, 1995, Suramin analogs, divalent cations and ATP-γ-S as inhibitors of ecto-ATPase, Naunyn-Schmiedeberg's Arch. Pharmacol. 351, 523.
3. 2U-purinoceptors, Br. J. Pharmacol. 116, 2413.
4. 2X-purinoceptors in rat vas deferens, Naunyn-Schmiedeberg's Arch. Pharmacol. 348, 684.
5. 2-purinoceptor antagonists discriminate three contraction-mediating receptors for ATP in rat vas deferens, Naunyn-Schmiedeberg's Arch. Pharmacol. 349, 74.
6. Bultmann, R., B. Driessen, J. Concalves and K. Starke, 1995, Functional consequences of inhibition of nucleotide breakdown in rat vas deferens: a study with Evans blue, Naunyn-Schmiedeberg's Arch. Pharmacol. 351, 553.
7. Burnstock, G., 1988, Sympathetic purinergic transmission in small blood vessels, Trends Pharmacol. Sci. 9, 116.
8. 2-purinoceptor?, Gen. Pharmacol. 16, 433.
9. 2X-purinoceptors, Br. J. Pharmacol. 90, 383.
10. Chinellato, A., E. Ragazzi, L. Pandolfo, G. Froldi, L. Caparrota and G. Fassina, 1992, Pharmacological characterization of ATP receptors mediating vasodilatation on isolated rabbit aorta, Gen. Pharmacol. 23, 861.
11. 2 purinergic receptors, J. Pharmacol. Exp. Ther. 265, 334.
12. Connolly, G.P. and P.J. Harrison, 1994, Reactive blue 2 discriminates between responses mediated by UTP and those evoked by ATP or α,β-methylene ATP on rat sympathetic ganglia, Eur. J. Pharmacol. 259, 95.
13. 2X-purinoceptor ligands, Br. J. Pharmacol. 113, 1432.
14. 2Y purinoceptors, Fundam, Clin. Pharmacol. 5, 387.
15. Dalziel, H.H. and D.P. Westfall, 1994, Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization, Pharmacol. Rev. 46, 449.
16. 2 purinoceptor antagonist in mouse vas deferens, Br. J. Pharmacol. 93, 243.
17. Eltze, M., B. Ullrich, E. Mutschler, U. Moser, E. Bungardt, T. Friebe, Ch. Gubitz, R. Tacke and G. Lambrecht, 1993, Characterization of muscarinic receptors mediating vasodilatation in rat perfused kidney, Eur. J. Pharmacol. 238, 343.
18. 2-purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses, Br. J. Pharmacol. 113, 853.
19. Fredholm, B.B., M.P. Abbracchio, G. Burnstock, J.W. Daly, T.K. Harden, K.A. Jacobson, P. Leff and M. Williams, 1994, VI. Nomenclature and classification of purinoceptors, Pharmacol. Rev. 46, 143.
20. Gordon, J.L., 1986, Extracellular ATP: effects, sources and fate, Biochem. J. 233, 309.
21. Gordon, E.L., J.D. Pearson, E.S. Dickinson, D. Moreau and L.L. Slakey, 1989, The hydrolysis of extracellular adenine nucleotides by arterial smooth muscle cells. Regulation of adenosine production at the cell surface, J. Biol, Chem. 264, 18986.
22. Hardebo, J.E., J. Kaahrstroem, C. Owman, L.G. Salford, 1987, Endothelium-dependent relaxation by uridine tri- and diphosphate in isolated human pial vessels. Blood Vessels 24, 150.
23. Holz, F.G. and M. Steinhausen, 1987, Renovascular effects of adenosine receptor agonists, Renal Physiol. 10, 272.
24. Hourani, S.M.O. and J.A. Chown, 1989, The effects of some possible inhibitors of ecto-nucleotidases on the breakdown and pharmacological effects of ATP in the guinea-pig urinary bladder, Gen. Pharmacol. 20, 413.
25. 2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder, Br. J. Pharmacol. 99, 617.
26. Inscho, E.W., K.D. Mitchell and L.G. Navar, 1994, Extracellular ATP in the regulation of renal microvascular function, FASEB J. 8, 319.
27. Keef, K.D., S.J. Pasco and D.M. Eckman, 1992, Purinergic relaxation and hyperpolarization in guinea-pig and rabbit coronary artery: role of the endothelium, J. Pharmacol. Exp. Ther. 260, 592.
28. 2X purinoceptors be classified pharmacologically?, Trends Pharmacol. Sci. 16, 168.
29. 2-purinoceptor-mediated responses, Eur. J. Pharmacol. 217, 217.
30. Le Hir, M. and B. Kaissling, 1993, Distribution and regulation of renal ecto-5′-nucleotidase: implications for physiological functions of adenosine, Am. J. Physiol. 264, F377.
31. 2Y purinoceptors, Br. J. Pharmacol. 114 (suppl.), 104P.
32. Needleman, P., M.S. Minkes and J.R. Douglas, 1970, Stimulation of prostaglandin biosynthesis by adenine nucleotides. Profile of prostaglandin release by perfused organs, Circ. Res. 34, 455.
33. O'Connor, S.E., 1992, Recent developments in the clasification and functional significance of receptors for ATP and UTP, evidence for nucleotide receptors, Life Sci. 50, 1657.
34. 2-purinoceptor subtypes in the isolated perfused mesenteric bed of the rat, Br. J. Pharmacol. 95, 637.
35. 2-purinoceptors in the cardiovascular system, Circulation 84, 1.
36. Ralevic, V. and G. Burnstock, 1991b, Effects of purines and pyrimidines on the rat mesenteric arterial bed, Circ. Res. 69, 1583.
37. 2 purinoceptors in the isolated mesenteric arterial bed of the golden hamster, 1995, Br. J. Pharmacol. 116 (Suppl.), 53P.
38. 2-purinoceptors: supporting evidence for purinergic innervation of the rabbit portal vein, Eur. J. Pharmacol. 40, 47.
39. 2 inhibits noradrenaline release and purinergic presser responses to renal nerve stimulation at 1 Hz in isolated kidneys of young spontaneously hypertensive rats, J. Hypertens. 8, 879.
40. Sabolic, I., O. Culic, S. Lin and D. Brown, 1992, Localization of ecto-ATPase in rat kidney and isolated renal cortical membrane vesicles, Am. J. Physiol. 262, F217.
41. Sakai, K., M. Akima and H. Nabata, 1979, A possible purinergic mechanism for reactive ischemia in isolated, cross-circulated rat kidney, Jpn. J. Pharmacol. 29, 235.
42. 2 adenosine receptors, Naunyn-Schmiedeberg's Arch. Pharmacol. 330, 212.
43. Schwanz, D.D. and K.U. Malik, 1989, Renal periarterial nerve stimulation-induced vasoconstriction at low frequencies is primarily due to release of a purinergic transmitter in the rat, J. Pharmacol. Exp. Ther. 250, 764.
44. Tagawa, H. and A.J. Vander, 1970, Effect of adenosine compounds on renal function and renin secretion in dogs, Circ. Res. 26, 327.
45. 2 purinoceptor classification, Br. J. Pharmacol. 113, 463.
46. 2X-receptor, in rabbit basilar artery: a receptor for pyrimidine nucleotides and a receptor for purine nucleotides, Naunyn-Schmiedeberg's Arch. Pharmacol. 341, 538.
47. Von Kügelgen, I. and K. Starke, 1991, Effekt of suramin on the ATP- and α,α-methylene ATP-induced constriction of the rabbit ear artery, Nucleosides Nucleotides 10, 1181.
48. 2-purinoceptors: evidence that dephosphorylation of ATP analogues reduces pharmacological potency, Eur. J. Pharmacol. 141, 123.
49. 2 (nucleotide) receptors mediating contraction and relaxation of rat aortic strips: possible physiological relevance, Eur. J. Pharmacol. 118, 37.
50. 2Y purinoceptor and nucleotide receptor-induced relaxation of precontracted bovine aortic collateral artery rings: Differential sensitivity to suramin and indomethacin, J. Pharmacol. Exp. Ther. 268, 881.
51. 2X-purinoceptors, Br. J. Pharmacol. 113, 1015.
52. Windscheif, U., O. Pfaff, A.U. Ziganshin, C.H.V. Hoyle, H.G. Bäumert, E. Mutschler, G. Burnstock and G. Lambrecht, 1995, Inhibitory action of PPADS on relaxant responses to adenine nucleotides or electrical stimulation in guinea-pig taenia coli and rat duodenum, Br. J. Pharmacol. 115, 1509.
53. Ziganshin, A.U., C.H.V. Hoyle, G. Lambrecht, E. Mutschler, H.G. Bäumert and G. Burnstock, 1994, Selective antagonism by PPADS in rabbit isolated blood vessels, Br. J. Pharmacol. 111, 923.